Skip to content

Timothy Lu

Chief Executive Officer at Senti Biosciences.

Earliest Form D on file: Jun 2026

Filed Jun 4, 2026

Senti Biosciences

Gene medicines whose dose can be tuned after treatment

Biotech, South San Francisco CA

Signed as Chief Executive Officer

$10M

sold of $40M offered

Form D

LinkedIn

Network

At Senti Biosciences

9 people

3 more at Senti Biosciences